Impel Pharmaceuticals

is developing and providing transformative therapies that have the potential to improve the lives of patients living with CNS diseases all over the world.

This is just the beginning. Impel Pharmaceuticals is committed to harnessing this potential beyond these current core indications. Impel Pharmaceuticals is actively considering partnerships, collaborations and licensing opportunities to explore the therapeutic potential of our technology and expertise with both small and large molecules.